SCHEMBL8034405

SCHEMBL8034405

NC1(c2cccc(F)c2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 1/20 0.55
▸ PTPN2 P17706 1/20 0.55
▸ HTR7 P34969 1/20 0.55
▸ KCNH2 Q12809 9/20 0.55
▸ CYP2D6 P10635 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ FNTA P49354 1/20 0.35
▸ FNTB P49356 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ DPP4 P27487 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3059138 0.86 PRKCA (0.69) PRKCAPTPN2HTR7KCNH2ALDH1A1
SCHEMBL8032698 0.84 HTR7 (0.59) PRKCAPTPN2HTR7KCNH2FNTA
SCHEMBL6888816 0.80 PRKCA (0.76) PRKCAPTPN2HTR7KCNH2ALDH1A1
SCHEMBL6888447 0.79 PRKCA (0.77) PRKCAPTPN2HTR7KCNH2
SCHEMBL30153039 0.78 KCNH2 (0.71) PRKCAPTPN2HTR7KCNH2CYP2D6
SCHEMBL13016557 0.77 KCNH2 (0.74) PRKCAPTPN2HTR7KCNH2GAA
SCHEMBL1769593 0.76 KCNH2 (0.70) PRKCAPTPN2HTR7KCNH2CYP2D6
SCHEMBL3777490 0.75 KCNH2 (0.58) PRKCAPTPN2HTR7KCNH2
SCHEMBL3041934 0.73 PRKCA (0.73) PRKCAPTPN2HTR7KCNH2
SCHEMBL3783069 0.73 PRKCA (0.53) PRKCAPTPN2HTR7KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009051715-A1 QUINOLIZIDINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK & CO., INC. (US) 2009-04-23 — — WO disclosed
Send feedback